Hoppenot Herve

Hoppenot Herve is listed in filings as Director at Bicycle Therapeutics plc. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to Bicycle Therapeutics plc (BCYC), Incyte Corp (INCY), and Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Jan 22, 2025 to Jan 6, 2026. Reported amounts are shown as $42.9K to $19.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.